Calidi Biotherapeutics Inc (CLDI)
2.03
-0.12
(-5.58%)
USD |
NYAM |
Nov 22, 11:22
Calidi Biotherapeutics Total Liabilities (Quarterly): 16.46M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 16.46M |
| June 30, 2024 | 18.18M |
| March 31, 2024 | 21.98M |
| December 31, 2023 | 18.25M |
| September 30, 2023 | 19.68M |
| Date | Value |
|---|---|
| June 30, 2023 | 73.89M |
| December 31, 2022 | 53.04M |
| September 30, 2022 | 45.54M |
| December 31, 2021 | 35.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
16.46M
Minimum
Sep 2024
73.89M
Maximum
Jun 2023
33.56M
Average
21.98M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| Lumos Pharma Inc | 12.55M |
| Harrow Inc | 293.92M |
| Allurion Technologies Inc | 115.49M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.657M |
| Shareholders Equity (Quarterly) | -10.28M |